Literature DB >> 22049166

Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study.

Denise L Jacobson1, Kunjal Patel, George K Siberry, Russell B Van Dyke, Linda A DiMeglio, Mitchell E Geffner, Janet S Chen, Elizabeth J McFarland, William Borkowsky, Margarita Silio, Roger A Fielding, Suzanne Siminski, Tracie L Miller.   

Abstract

BACKGROUND: Associations between abnormal body fat distribution and clinical variables are poorly understood in pediatric HIV disease.
OBJECTIVE: Our objective was to compare total body fat and its distribution in perinatally HIV-infected and HIV-exposed but uninfected (HEU) children and to evaluate associations with clinical variables.
DESIGN: In a cross-sectional analysis, children aged 7-16 y in the Pediatric HIV/AIDS Cohort Study underwent regionalized measurements of body fat via anthropometric methods and dual-energy X-ray absorptiometry. Multiple linear regression was used to evaluate body fat by HIV, with adjustment for age, Tanner stage, race, sex, and correlates of body fat in HIV-infected children. Percentage total body fat was compared with NHANES data.
RESULTS: Males accounted for 47% of the 369 HIV-infected and 51% of the 176 HEU children. Compared with HEU children, HIV-infected children were older, were more frequently non-Hispanic black, more frequently had Tanner stage ≥3, and had lower mean height (-0.32 compared with 0.29), weight (0.13 compared with 0.70), and BMI (0.33 compared with 0.63) z scores. On average, HIV-infected children had a 5% lower percentage total body fat (TotF), a 2.8% lower percentage extremity fat (EF), a 1.4% higher percentage trunk fat (TF), and a 10% higher trunk-to-extremity fat ratio (TEFR) than did the HEU children and a lower TotF compared with NHANES data. Stavudine use was associated with lower EF and higher TF and TEFR. Non-nucleotide reverse transcriptase inhibitor use was associated with higher TotF and EF and lower TEFR.
CONCLUSION: Although BMI and total body fat were significantly lower in the HIV-infected children than in the HEU children, body fat distribution in the HIV-infected children followed a pattern associated with cardiovascular disease risk and possibly related to specific antiretroviral drugs.

Entities:  

Mesh:

Year:  2011        PMID: 22049166      PMCID: PMC3252548          DOI: 10.3945/ajcn.111.020271

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  54 in total

1.  Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV-infected children.

Authors:  Alessandra Viganò; Stefano Mora; Corrado Testolin; Sabrina Beccio; Laura Schneider; Dorella Bricalli; Angelo Vanzulli; Paola Manzoni; Paolo Brambilla
Journal:  J Acquir Immune Defic Syndr       Date:  2003-04-15       Impact factor: 3.731

2.  Relation of body fat patterning to lipid and lipoprotein concentrations in children and adolescents: the Bogalusa Heart Study.

Authors:  D S Freedman; S R Srinivasan; D W Harsha; L S Webber; G S Berenson
Journal:  Am J Clin Nutr       Date:  1989-11       Impact factor: 7.045

Review 3.  Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study.

Authors:  Henry C McGill; C Alex McMahan; Samuel S Gidding
Journal:  Circulation       Date:  2008-03-04       Impact factor: 29.690

4.  Prevalence and trends of severe obesity among US children and adolescents.

Authors:  Joseph A Skelton; Stephen R Cook; Peggy Auinger; Jonathan D Klein; Sarah E Barlow
Journal:  Acad Pediatr       Date:  2009-06-27       Impact factor: 3.107

5.  Effects of protease inhibitors on glucose tolerance, lipid metabolism, and body composition in children and adolescents infected with human immunodeficiency virus.

Authors:  Berrin Ergun-Longmire; Karen Lin-Su; Ann M Dunn; Lily Chan; Kirsis Ham; Cristina Sison; Joseph Stavola; Maria G Vogiatzi
Journal:  Endocr Pract       Date:  2006 Sep-Oct       Impact factor: 3.443

6.  Lipodystrophy in HIV-infected children is associated with high viral load and low CD4+ -lymphocyte count and CD4+ -lymphocyte percentage at baseline and use of protease inhibitors and stavudine.

Authors:  S M Arpadi; P A Cuff; M Horlick; J Wang; D P Kotler
Journal:  J Acquir Immune Defic Syndr       Date:  2001-05-01       Impact factor: 3.731

7.  LIPODYSTROPHY SYNDROME IN HIV-INFECTED CHILDREN ON HAART.

Authors:  Steve Innes; Leon Levin; Mark Cotton
Journal:  South Afr J HIV Med       Date:  2009-12       Impact factor: 2.744

8.  Younger age at HAART initiation is associated with more rapid growth reconstitution.

Authors:  Christine J McGrath; Michael H Chung; Barbra A Richardson; Sarah Benki-Nugent; Danson Warui; Grace C John-Stewart
Journal:  AIDS       Date:  2011-01-28       Impact factor: 4.177

9.  Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.

Authors:  Grace McComsey; Nasreen Bhumbra; Jen-Fu Ma; Mobeen Rathore; Ana Alvarez
Journal:  Pediatrics       Date:  2003-03       Impact factor: 7.124

10.  Changes and tracking of fat mass in pubertal girls.

Authors:  Eva E Vink; Silvia C C M van Coeverden; Edgar G van Mil; Bram A Felius; Frank J M van Leerdam; Henriëtte A Delemarre-van de Waal
Journal:  Obesity (Silver Spring)       Date:  2009-10-29       Impact factor: 5.002

View more
  34 in total

1.  Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy.

Authors:  George K Siberry; Denise L Jacobson; Heidi J Kalkwarf; Julia W Wu; Linda A DiMeglio; Ram Yogev; Katherine M Knapp; Justin J Wheeler; Laurie Butler; Rohan Hazra; Tracie L Miller; George R Seage; Russell B Van Dyke; Emily Barr; Mariam Davtyan; Lynne M Mofenson; Kenneth C Rich
Journal:  Clin Infect Dis       Date:  2015-06-09       Impact factor: 9.079

2.  Physical fitness in children infected with the human immunodeficiency virus: associations with highly active antiretroviral therapy.

Authors:  Gabriel Somarriba; Gabriela Lopez-Mitnik; David A Ludwig; Daniela Neri; Natasha Schaefer; Steven E Lipshultz; Gwendolyn B Scott; Tracie L Miller
Journal:  AIDS Res Hum Retroviruses       Date:  2012-07-31       Impact factor: 2.205

3.  High Burden of Morbidity and Mortality but Not Growth Failure in Infants Exposed to but Uninfected with Human Immunodeficiency Virus in Tanzania.

Authors:  Lindsey M Locks; Karim P Manji; Roland Kupka; Enju Liu; Rodrick Kisenge; Christine M McDonald; Said Aboud; Molin Wang; Wafaie W Fawzi; Christopher P Duggan
Journal:  J Pediatr       Date:  2016-11-07       Impact factor: 4.406

4.  Third Trimester Vitamin D Status Is Associated With Birth Outcomes and Linear Growth of HIV-Exposed Uninfected Infants in the United States.

Authors:  Christopher R Sudfeld; Denise L Jacobson; Noé M Rueda; Daniela Neri; Armando J Mendez; Laurie Butler; Suzanne Siminski; Kristy M Hendricks; Claude A Mellins; Christopher P Duggan; Tracie L Miller
Journal:  J Acquir Immune Defic Syndr       Date:  2019-07-01       Impact factor: 3.731

5.  Growth at 2 Years of Age in HIV-exposed Uninfected Children in the United States by Trimester of Maternal Antiretroviral Initiation.

Authors:  Denise L Jacobson; Kunjal Patel; Paige L Williams; Mitchell E Geffner; George K Siberry; Linda A DiMeglio; Marilyn J Crain; Ayesha Mirza; Janet S Chen; Elizabeth McFarland; Deborah Kacanek; Margarita Silio; Kenneth Rich; William Borkowsky; Russell B Van Dyke; Tracie L Miller
Journal:  Pediatr Infect Dis J       Date:  2017-02       Impact factor: 2.129

6.  Alendronate Improves Bone Mineral Density in Children and Adolescents Perinatally Infected With Human Immunodeficiency Virus With Low Bone Mineral Density for Age.

Authors:  Denise L Jacobson; Jane C Lindsey; Catherine Gordon; Rohan Hazra; Hans Spiegel; Flavia Ferreira; Fabiana R Amaral; Jesica Pagano-Therrien; Aditya Gaur; Kathy George; Jane Benson; George K Siberry
Journal:  Clin Infect Dis       Date:  2020-08-22       Impact factor: 9.079

7.  Bone mineral density in children and adolescents with perinatal HIV infection.

Authors:  Linda A DiMeglio; JiaJia Wang; George K Siberry; Tracie L Miller; Mitchell E Geffner; Rohan Hazra; William Borkowsky; Janet S Chen; Laurie Dooley; Kunjal Patel; Russell B van Dyke; Roger A Fielding; Yared Gurmu; Denise L Jacobson
Journal:  AIDS       Date:  2013-01-14       Impact factor: 4.177

8.  Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy.

Authors:  Stephen Arpadi; Stephanie Shiau; Renate Strehlau; Leigh Martens; Faeezah Patel; Ashraf Coovadia; Elaine J Abrams; Louise Kuhn
Journal:  Arch Dis Child       Date:  2012-12-05       Impact factor: 3.791

9.  Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus.

Authors:  Kunjal Patel; Jiajia Wang; Denise L Jacobson; Steven E Lipshultz; David C Landy; Mitchell E Geffner; Linda A Dimeglio; George R Seage; Paige L Williams; Russell B Van Dyke; George K Siberry; William T Shearer; Luciana Young; Gwendolyn B Scott; James D Wilkinson; Stacy D Fisher; Thomas J Starc; Tracie L Miller
Journal:  Circulation       Date:  2013-12-23       Impact factor: 29.690

10.  Prevalence of proteinuria and elevated serum cystatin C among HIV-Infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) study.

Authors:  Kristal J Aaron; Mirjam-Colette Kempf; Robert H Christenson; Craig M Wilson; Paul Muntner; Sadeep Shrestha
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.